Undifferentiated pelvic adenocarcinomas: Diagnostic potential of protein profiling and multivariate analysis

International Journal of Colorectal Disease

Volumn 23, Issue 5, 2008, Pages 483-491

  Roblick, U J ^a,b   Bader, F G ^a,b   Lenander, C ^b   Hellman, U ^c   Zimmermann, K ^a   Becker, S ^b   Ost, A ^b   Alaiya, A ^d   Bruch, H P ^a   Keller, R ^a   Mirow, L ^a   Franzen B ^e   Ried, T ^f   Auer, G ^b   Habermann, J K ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^e ASTRAZENECA R AND D   (Sweden)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

2 DE; Colon cancer; Differential diagnosis; Ovarian cancer; Pelvic carcinoma; Principal component analysis; Proteomics

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7;

ARTICLE; CANCER CELL CULTURE; CLINICAL DECISION MAKING; COLON ADENOCARCINOMA; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIVARIATE ANALYSIS; OVARY ADENOCARCINOMA; PELVIC ADENOCARCINOMA; PELVIS CANCER; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROFILING; PROTEOMICS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RELIABILITY; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADENOCARCINOMA; CELL DIFFERENTIATION; CLUSTER ANALYSIS; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASMS, UNKNOWN PRIMARY; OVARIAN NEOPLASMS; PELVIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PRINCIPAL COMPONENT ANALYSIS; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

EID: 41149176384     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0448-6     Document Type: Article

References (35)

1. Alaiya A, Roblick U, Egevad L, Carlsson A, Franzen B, Volz D, Huwendiek S, Linder S, Auer G (2000) Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma. Anal Cell Pathol 21:1-9
2. Alaiya AA, Franzen B, Fujioka K, Moberger B, Schedvins K, Silfversvard C, Linder S, Auer G (1997) Phenotypic analysis of ovarian carcinoma: polypeptide expression in benign, borderline and malignant tumors. Int J Cancer 73:678-683
3. Alaiya AA, Franzen B, Hagman A, Dysvik B, Roblick UJ, Becker S, Moberger B, Auer G, Linder S (2002) Molecular classification of borderline ovarian tumors using hierarchical cluster analysis of protein expression profiles. Int J Cancer 98:895-899
4. Alaiya AA, Franzen B, Hagman A, Silfversward C, Moberger B, Linder S, Auer G (2000) Classification of human ovarian tumors using multivariate data analysis of polypeptide expression patterns. Int J Cancer 86:731-736
5. Alaiya AA, Oppermann M, Langridge J, Roblick U, Egevad L, Brindstedt S, Hellstrom M, Linder S, Bergman T, Jornvall H, Auer G (2001) Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry. Cell Mol Life Sci 58:307-311
6. Anderson DJ, Kuhns JS, Vasil ML, Gerding DN, Janoff EN (1991) DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J Clin Microbiol 29:648-649
7. Ashraf M, Zhang PJ (2000) Cytokeratin expression in rectal adenocarcinoma. Annual Meeting of the American Society of Pathologists
8. Berezowski K, Stastny JF, Kornstein MJ (1996) Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 9:426-429
9. Bloom G, Yang IV, Boulware D, Kwong KY, Coppola D, Eschrich S, Quackenbush J, Yeatman TJ (2004) Multi-platform, multi-site, microarray-based human tumor classification. Am J Pathol 164:9-16
10. Bloom GC, Eschrich S, Zhou JX, Coppola D, Yeatman TJ (2007) Elucidation of a protein signature discriminating six common types of adenocarcinoma. Int J Cancer 120:769-775
11. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
12. Chu P, Wu E, Weiss LM (2000) Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases. Mod Pathol 13:962-972
13. Chuman Y, Bergman A, Ueno T, Saito S, Sakaguchi K, Alaiya AA, Franzen B, Bergman T, Arnott D, Auer G, Appella E, Jornvall H, Linder S (1999) Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas. FEBS Lett 462:129-134
14. Franzen B, Auer G, Alaiya AA, Eriksson E, Uryu K, Hirano T, Okuzawa K, Kato H, Linder S (1996) Assessment of homogeneity in polypeptide expression in breast carcinomas shows widely variable expression in highly malignant tumors. Int J Cancer 69:408-414
15. Franzen B, Hirano T, Okuzawa K, Uryu K, Alaiya AA, Linder S, Auer G (1995) Sample preparation of human tumors prior to two-dimensional electrophoresis of proteins. Electrophoresis 16:1087-1089
16. Franzen B, Linder S, Alaiya AA, Eriksson E, Fujioka K, Bergman AC, Jornvall H, Auer G (1997) Analysis of polypeptide expression in benign and malignant human breast lesions. Electrophoresis 18:582-587
17. Franzen B, Linder S, Alaiya AA, Eriksson E, Uruy K, Hirano T, Okuzawa K, Auer G (1996) Analysis of polypeptide expression in benign and malignant human breast lesions: Down-regulation of cytokeratins. Br J Cancer 74:1632-1638
18. Franzen B, Linder S, Uryu K, Alaiya AA, Hirano T, Kato H, Auer G (1996) Expression of tropomyosin isoforms in benign and malignant human breast lesions. Br J Cancer 73:909-913
19. Frohlich C, Albrechtsen R, Dyrskjot L, Rudkjaer L, Orntoft TF, Wewer UM (2006) Molecular profiling of ADAM12 in human bladder cancer. Clin Cancer Res 12:7359-7368
20. Garrels JI (1989) The QUEST system for quantitative analysis of two-dimensional gels. J Biol Chem 264:5269-5282
21. Greco FA, Burris HA 3rd, Erland JB, Gray JR, Kalman LA, Schreeder MT, Hainsworth JD (2000) Carcinoma of unknown primary site. Cancer 89:2655-2660
22. Lagendijk JH, Mullink H, Van Diest PJ, Meijer GA, Meijer CJ (1998) Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: Differential diagnosis between colonic and ovarian carcinomas as primary sites. Hum Pathol 29:491-497
23. Loy TS, Calaluce RD, Keeney GL (1996) Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol 9:1040-1044
24. Multhaupt HA, Arenas-Elliott CP, Warhol MJ (1999) Comparison of glycoprotein expression between ovarian and colon adenocarcinomas. Arch Pathol Lab Med 123:909-916
25. Nishizuka S, Charboneau L, Young L, Major S, Reinhold WC, Waltham M, Kouros-Mehr H, Bussey KJ, Lee JK, Espina V, Munson PJ, Petricoin E 3rd, Liotta LA, Weinstein JN (2003) Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci U S A 100:14229-14234
26. Nishizuka S, Chen ST, Gwadry FG, Alexander J, Major SM, Scherf U, Reinhold WC, Waltham M, Charboneau L, Young L, Bussey KJ, Kim S, Lababidi S, Lee JK, Pittaluga S, Scudiero DA, Sausville EA, Munson PJ, Petricoin EF 3rd, Liotta LA, Hewitt SM, Raffeld M, Weinstein JN (2003) Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res 63:5243-5250
27. Okuzawa K, Franzen B, Lindholm J, Linder S, Hirano T, Bergman T, Ebihara Y, Kato H, Auer G (1994) Characterization of gene expression in clinical lung cancer materials by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 15:382-390
28. Oppermann M, Cols N, Nyman T, Helin J, Saarinen J, Byman I, Toran N, Alaiya AA, Bergman T, Kalkkinen N, Gonzalez-Duarte R, Jornvall H (2000) Identification of foetal brain proteins by two-dimensional gel electrophoresis and mass spectrometry comparison of samples from individuals with or without chromosome 21 trisomy. Eur J Biochem 267:4713-4719
29. Ostergaard M, Rasmussen HH, Nielsen HV, Vorum H, Orntoft TF, Wolf H, Celis JE (1997) Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res 57:4111-4117
30. Pavlidis N (2007) Forty years experience of treating cancer of unknown primary. Acta Oncol 46:592-601
31. Rabilloud T, Vuillard L, Gilly C, Lawrence JJ (1994) Silver-staining of proteins in polyacrylamide gels: A general overview. Cell Mol Biol (Noisy-le-grand) 40:57-75
32. Roblick UJ, Hirschberg D, Habermann JK, Palmberg C, Becker S, Kruger S, Gustafsson M, Bruch HP, Franzen B, Ried T, Bergmann T, Auer G, Jornvall H (2004) Sequential proteome alterations during genesis and progression of colon cancer. Cell Mol Life Sci 61:1246-1255
33. Stulik J, Koupilova K, Osterreicher J, Knizek J, Macela A, Bures J, Jandik P, Langr F, Dedic K, Jungblut PR (1999) Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. Electrophoresis 20:3638-3646
34. Vang R, Gown AM, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Ronnett BM (2006) Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: Analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Am J Surg Pathol 30:1130-1139
35. Wauters CC, Smedts F, Gerrits LG, Bosman FT, Ramaekers FC (1995) Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol 26:852-855